Metoprolol: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
The active substance metoprolol is employed either as ''metoprolol [[succinic acid|succinate]]'' or as ''metoprolol [[tartrate]]''. The [[tartrate]] is an immediate-release and the [[succinic acid|succinate]] is an extended-release [[Pharmaceutical formulation|formulation]]. | The active substance metoprolol is employed either as ''metoprolol [[succinic acid|succinate]]'' or as ''metoprolol [[tartrate]]''. The [[tartrate]] is an immediate-release and the [[succinic acid|succinate]] is an extended-release [[Pharmaceutical formulation|formulation]]. | ||
{{Beta blockers}} | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
[[Category:Beta blockers]] | |||
[[Category:Antiarrhythmic agents]] | |||
Revision as of 02:56, 25 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Metoprolol succinate (Toprol XL, Toprolxl XL)
Metoprolol tartrate (Lopressor)
Overview
Metoprolol is a competitive, β1-selective (cardioselective) blocker used in treatment of angina pectoris, hypertension, arrhythmia, and migraine. Common adverse reactions include bradyarrhythmia, heart block, heart failure, hypotension, pruritus, rash, constipation, diarrhea, indigestion, nausea, dizziness, fatigue, headache, depression, dyspnea, and wheezing.
The active substance metoprolol is employed either as metoprolol succinate or as metoprolol tartrate. The tartrate is an immediate-release and the succinate is an extended-release formulation.